Cargando…

Development, validation and transfer to clinical practice of a mobile application for the treatment of smoking

OBJECTIVE: The main objective is to transfer to clinical practice a new smoking cessation application (“Vive sin Tabaco” a) in all health centers of the public Basque Health Service. DESIGN: An implementation study of a smoking cessation program previously validated. After implementation, a retrospe...

Descripción completa

Detalles Bibliográficos
Autores principales: Cobos-Campos, Raquel, Apiñaniz, Antxon, Sáez de Lafuente, Arantza, Parraza, Naiara
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142851/
https://www.ncbi.nlm.nih.gov/pubmed/35636019
http://dx.doi.org/10.1016/j.aprim.2022.102363
_version_ 1784715662075101184
author Cobos-Campos, Raquel
Apiñaniz, Antxon
Sáez de Lafuente, Arantza
Parraza, Naiara
author_facet Cobos-Campos, Raquel
Apiñaniz, Antxon
Sáez de Lafuente, Arantza
Parraza, Naiara
author_sort Cobos-Campos, Raquel
collection PubMed
description OBJECTIVE: The main objective is to transfer to clinical practice a new smoking cessation application (“Vive sin Tabaco” a) in all health centers of the public Basque Health Service. DESIGN: An implementation study of a smoking cessation program previously validated. After implementation, a retrospective study has been carried out to evaluate its use under normal conditions. SITE: The process of transfer to clinical practice has been held in several phases; first a pilotage in four health centers of Alava and subsequently, when all reported incidents were resolved, it was extended to all health centers of the Basque Health Service. INTERVENTION AND MAIN MEASUREMENT: Development of “Vive sin Tabaco”; a corporate tool for smoking cessation, and its transfer to clinical practice. All interested health care workers received training on how to use the application. User manuals for both patients and professionals were developed. Smoking cessation rates at 12 months during implementation were also collected. RESULTS: The percentage of patients of post pilot phase who quit smoking at 12 months was 14.1%. CONCLUSIONS: The conception of “Vive sin tabaco” as a corporate tool for smoking cessation, available in all health centers of Basque Health Service, has been long and arduous, and has required the participation of health professionals and patients as end-users in order to obtain a tool that adapts to their expectations and guarantees greater usability and satisfaction. This application is being effective as an adjuvant tool to health advice.
format Online
Article
Text
id pubmed-9142851
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher Elsevier
record_format MEDLINE/PubMed
spelling pubmed-91428512022-05-29 Development, validation and transfer to clinical practice of a mobile application for the treatment of smoking Cobos-Campos, Raquel Apiñaniz, Antxon Sáez de Lafuente, Arantza Parraza, Naiara Aten Primaria Original Article OBJECTIVE: The main objective is to transfer to clinical practice a new smoking cessation application (“Vive sin Tabaco” a) in all health centers of the public Basque Health Service. DESIGN: An implementation study of a smoking cessation program previously validated. After implementation, a retrospective study has been carried out to evaluate its use under normal conditions. SITE: The process of transfer to clinical practice has been held in several phases; first a pilotage in four health centers of Alava and subsequently, when all reported incidents were resolved, it was extended to all health centers of the Basque Health Service. INTERVENTION AND MAIN MEASUREMENT: Development of “Vive sin Tabaco”; a corporate tool for smoking cessation, and its transfer to clinical practice. All interested health care workers received training on how to use the application. User manuals for both patients and professionals were developed. Smoking cessation rates at 12 months during implementation were also collected. RESULTS: The percentage of patients of post pilot phase who quit smoking at 12 months was 14.1%. CONCLUSIONS: The conception of “Vive sin tabaco” as a corporate tool for smoking cessation, available in all health centers of Basque Health Service, has been long and arduous, and has required the participation of health professionals and patients as end-users in order to obtain a tool that adapts to their expectations and guarantees greater usability and satisfaction. This application is being effective as an adjuvant tool to health advice. Elsevier 2022-07 2022-05-26 /pmc/articles/PMC9142851/ /pubmed/35636019 http://dx.doi.org/10.1016/j.aprim.2022.102363 Text en © 2022 The Authors https://creativecommons.org/licenses/by-nc-nd/4.0/This is an open access article under the CC BY-NC-ND license (http://creativecommons.org/licenses/by-nc-nd/4.0/).
spellingShingle Original Article
Cobos-Campos, Raquel
Apiñaniz, Antxon
Sáez de Lafuente, Arantza
Parraza, Naiara
Development, validation and transfer to clinical practice of a mobile application for the treatment of smoking
title Development, validation and transfer to clinical practice of a mobile application for the treatment of smoking
title_full Development, validation and transfer to clinical practice of a mobile application for the treatment of smoking
title_fullStr Development, validation and transfer to clinical practice of a mobile application for the treatment of smoking
title_full_unstemmed Development, validation and transfer to clinical practice of a mobile application for the treatment of smoking
title_short Development, validation and transfer to clinical practice of a mobile application for the treatment of smoking
title_sort development, validation and transfer to clinical practice of a mobile application for the treatment of smoking
topic Original Article
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9142851/
https://www.ncbi.nlm.nih.gov/pubmed/35636019
http://dx.doi.org/10.1016/j.aprim.2022.102363
work_keys_str_mv AT coboscamposraquel developmentvalidationandtransfertoclinicalpracticeofamobileapplicationforthetreatmentofsmoking
AT apinanizantxon developmentvalidationandtransfertoclinicalpracticeofamobileapplicationforthetreatmentofsmoking
AT saezdelafuentearantza developmentvalidationandtransfertoclinicalpracticeofamobileapplicationforthetreatmentofsmoking
AT parrazanaiara developmentvalidationandtransfertoclinicalpracticeofamobileapplicationforthetreatmentofsmoking